APA

Cortes J., Di Cosimo S., Climent M. A., Cortés-Funes H., Lluch A., Gascón P., Mayordomo J. I., Gil M., Benavides M., Cirera L., Ojeda B., Rodríguez C. A., Trigo J. M., Vazquez J., Regueiro P., Dorado J. F. & Baselga J. (20090507). Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Cortes Javier, Di Cosimo Serena, Climent Miguel A, Cortés-Funes Hernán, Lluch Ana, Gascón Pere, Mayordomo José I, Gil Miguel, Benavides Manuel, Cirera Lluís, Ojeda Belén, Rodríguez César A, Trigo José M, Vazquez Josep, Regueiro Pilar, Dorado Juan F and Baselga José. 20090507. Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Cortes J., Di Cosimo S., Climent M. A., Cortés-Funes H., Lluch A., Gascón P., Mayordomo J. I., Gil M., Benavides M., Cirera L., Ojeda B., Rodríguez C. A., Trigo J. M., Vazquez J., Regueiro P., Dorado J. F. and Baselga J. (20090507). Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Cortes Javier, Di Cosimo Serena, Climent Miguel A, Cortés-Funes Hernán, Lluch Ana, Gascón Pere, Mayordomo José I, Gil Miguel, Benavides Manuel, Cirera Lluís, Ojeda Belén, Rodríguez César A, Trigo José M, Vazquez Josep, Regueiro Pilar, Dorado Juan F and Baselga José. Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20090507.